Clinical development of two replication-defective chimpanzee adenovirus (ADC) vectors, termed ADC6 and ADC7
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272201700057C
- Awardee
-
The Wistar Institute Of Anatomy And Biology UEI DW1XZMGNFBL4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $149,120
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2016058 Solicitation number
- Staged Vaccine Development Award Notice · Posted Feb 25, 2016
- Contract value 1% obligated
-
- $149,120.02 Current, with exercised options
- $16,164,958.02 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Philadelphia, PA 19104, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Funding Only Action | -$4,327 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $153,447 |
About this award
This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to The Wistar Institute of Anatomy and Biology, a non-profit organization. The $16,164,958.02 contract is for the clinical development of two replication-defective chimpanzee adenovirus (ADC) vectors, ADC6 and ADC7. The contract does not have a set-aside designation and is expected to be completed by July 31, 2024. The Wistar Institute has previously served as a subcontractor on influenza vaccine research projects funded by the NIH and is currently working on developing synthetic DNA-encoded monoclonal antibodies targeting COVID-19 under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the Defense Advanced Research Projects Agency.
Quick answers
Who was awarded contract HHSN272201700057C?
HHSN272201700057C was awarded to The Wistar Institute Of Anatomy And Biology by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2017.
How much is contract HHSN272201700057C worth?
The government has obligated $149,120 on HHSN272201700057C. Its potential value, with all options, is $16,164,958.
Was contract HHSN272201700057C competed?
The extent of competition for HHSN272201700057C was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award